Medical applications and biotechnological advances, including magnetic resonance
imaging, cell separation and detection, tissue repair, magnetic hyperthermia and drug …

Simple Summary The advancement of nanotechnology over the last three decades has
given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was …

Radiation therapy (RT) including external beam radiotherapy (EBRT) and internal
radioisotope therapy (RIT) has been widely used for clinical cancer treatment. However …

The microenvironment characteristics of solid tumors, renowned as barriers that harshly
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …

The development of nanoparticles (NPs) for use in all facets of oncological disease
detection and therapy has shown great progress over the past two decades. NPs have been …

Nanomaterials, that is, materials made up of individual units between 1 and 100
nanometers, have lately involved a lot of attention since they offer a lot of potential in many …

Nanomedicine is a speedily growing area of medical research that is focused on develo**
nanomaterials for the prevention, diagnosis, and treatment of diseases. Nanomaterials with …

Magnetic nanomaterials belong to a class of highly-functionalizable tools for cancer therapy
owing to their intrinsic magnetic properties and multifunctional design that provides a …

Rapid growth in nanoparticles (NPs) as delivery systems holds vast promise to promote
therapeutic approaches for cancer treatment. Presently, a diverse array of NPs with unique …

Objective: Docetaxel (DTX) remains the only effective drug for prolonging survival and
improving quality of life of metastatic castration-resistant prostate cancer (mCRPC) patients …